Literature DB >> 10931135

The C5a receptor is expressed by human renal proximal tubular epithelial cells.

R Zahedi1, M Braun, R A Wetsel, B H Ault, A Khan, T R Welch, M Frenzke, A E Davis.   

Abstract

The C5a receptor is expressed by a variety of cell types. These studies demonstrate by immunohistochemistry that the receptor is present on the surface of proximal and distal tubular epithelial cells from normal kidney. In addition, the receptor was detected on transitional epithelial cells of the ureter and bladder. Primary proximal tubular cultures and a proximal tubular cell line both also expressed the C5a receptor, as demonstrated by immunofluorescence and by FACS analysis. The presence of mRNA encoding the receptor was confirmed by reverse transcriptase-polymerase chain reaction analysis. As opposed to its effect on glomerular mesangial cells, the receptor did not mediate a proliferative response by the proximal tubular cells. C5a also did not enhance the synthesis/secretion of transforming growth factor-beta 1, monocyte chemoattractant protein-1, platelet-derived growth factor-AB or tumour necrosis factor-alpha by cultured proximal tubular cells. Therefore, although the C5a receptor clearly is expressed by proximal tubular cells, clarification of its functional relevance on this cell type awaits further studies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931135      PMCID: PMC1905711          DOI: 10.1046/j.1365-2249.2000.01249.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  51 in total

1.  Inhibition of interleukin-6 synthesis in an animal model of septic shock by anti-C5a monoclonal antibodies.

Authors:  U Höpken; M Mohr; A Strüber; H Montz; H Burchardi; O Götze; M Oppermann
Journal:  Eur J Immunol       Date:  1996-05       Impact factor: 5.532

2.  In vitro and in vivo dependency of chemokine generation on C5a and TNF-alpha.

Authors:  B J Czermak; V Sarma; N M Bless; H Schmal; H P Friedl; P A Ward
Journal:  J Immunol       Date:  1999-02-15       Impact factor: 5.422

3.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

4.  Chemokine expression in experimental tubulointerstitial nephritis.

Authors:  W W Tang; M Qi; J S Warren; G Y Van
Journal:  J Immunol       Date:  1997-07-15       Impact factor: 5.422

5.  C5a-mediated release of interleukin 6 by human monocytes.

Authors:  W Scholz; M R McClurg; G J Cardenas; M Smith; D J Noonan; T E Hugli; E L Morgan
Journal:  Clin Immunol Immunopathol       Date:  1990-11

6.  Cuprophane haemodialysis induces upregulation of LPS receptor (CD14) on monocytes: role of complement activation.

Authors:  A Marchant; C Tielemans; C Husson; K Gastaldello; T Schurmans; D De Groote; J Duchow; L Vanherweghem; M Goldman
Journal:  Nephrol Dial Transplant       Date:  1996-04       Impact factor: 5.992

7.  Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries.

Authors:  M D Botney; L R Kaiser; J D Cooper; R P Mecham; D Parghi; J Roby; W C Parks
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

Review 8.  Structure, function and cellular expression of complement anaphylatoxin receptors.

Authors:  R A Wetsel
Journal:  Curr Opin Immunol       Date:  1995-02       Impact factor: 7.486

9.  Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia.

Authors:  M Lacy; J Jones; S R Whittemore; D L Haviland; R A Wetsel; S R Barnum
Journal:  J Neuroimmunol       Date:  1995-08       Impact factor: 3.478

10.  The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Authors:  C G Cochrane; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307

View more
  19 in total

Review 1.  Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.

Authors:  M A Khan; J L Hsu; A M Assiri; D C Broering
Journal:  Clin Exp Immunol       Date:  2015-11-05       Impact factor: 4.330

Review 2.  New insights into cellular mechanisms during sepsis.

Authors:  Laszlo M Hoesel; Hongwei Gao; Peter A Ward
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  The role of complement in danger sensing and transmission.

Authors:  Jörg Köhl
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  Leaked protein and interstitial damage in the kidney: is complement the missing link?

Authors:  N S Sheerin; S H Sacks
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

Review 5.  Complement activation in progressive renal disease.

Authors:  Amy Fearn; Neil Stephen Sheerin
Journal:  World J Nephrol       Date:  2015-02-06

6.  Increased concentration of the complement split product C5a in acute pyelonephritis during pregnancy.

Authors:  Eleazar Soto; Karina Richani; Roberto Romero; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Jyh Kae Nien; Samuel Edwin; Yeon Mee Kim; Joon-Seok Hong; Luis Goncalves; Moshe Mazor
Journal:  J Matern Fetal Neonatal Med       Date:  2005-04

7.  C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritis.

Authors:  T R Welch; M Frenzke; D Witte; A E Davis
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

8.  Does this case hold the answer to one of the worse types of pain in medicine--that of loin pain haematuria syndrome (LPHS).

Authors:  Alan Russell; Suman Chatterjee; Michael Seed
Journal:  BMJ Case Rep       Date:  2015-04-26

9.  Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells.

Authors:  Lei Sun; Ren-Feng Guo; Hongwei Gao; J Vidya Sarma; Firas S Zetoune; Peter A Ward
Journal:  FASEB J       Date:  2009-07-20       Impact factor: 5.191

10.  Increased C5a receptor expression in sepsis.

Authors:  Niels C Riedemann; Ren-Feng Guo; Thomas A Neff; Ines J Laudes; Katie A Keller; Vidya J Sarma; Maciej M Markiewski; Dimitrios Mastellos; Christoph W Strey; Carl L Pierson; John D Lambris; Firas S Zetoune; Peter A Ward
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.